# A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease

> **NCT02127476** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 57 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** KHK6640
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT02127476
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2024-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02127476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02127476, "A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02127476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*